Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ABVC vs ASTI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABVC Captures Overall Composite Edge (47.4 HOLD vs 44.5 HOLD), While ASTI Leads 3–2 on Growth & Valuation Pillars

ABVC Overall Winner 6-Pillar Tally: ABVC 2 – 3 ASTI (1 Tie) Matrix Metrics: ABVC 6 – 3 ASTI

As of Nov 20, 2026, ABVC BioPharma, Inc. (ABVC) captures the overall head-to-head institutional edge over Ascent Solar Technologies, Inc. (ASTI) on higher Unified Composite conviction (47.4/100 HOLD vs. 44.5/100 HOLD) after splitting the core matrix 6–3 (led by Growth & Scale, Profitability & Quality), while ASTI wins 3–2 across the 6-pillar growth and valuation breakdown. ABVC trades at $0.87 (N/M Forward P/E, 0.0% operating margin) versus ASTI at $0.77 (14.4x Forward P/E, -2759.6% operating margin).

  • Growth vs. Quality Trade-Off: ABVC earns the overall head-to-head edge with a stronger Unified Composite Score (47.4/100 HOLD vs. ASTI 44.5/100 HOLD) and 1.24β · 44% Vol risk profile, whereas ASTI leads top-line expansion (+514.3% YoY revenue growth, 0.96x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: ABVC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 35.2); meanwhile ASTI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABVC vs ASTI
ABVC NASDAQ Head-to-Head Winner
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap $23.9M
TTM Revenue $797,916
Forward P/E N/M
Beta / 30D Vol 1.24β · 44% Vol
Unified Composite Score
47.4 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 35
RSI-14: 35.2 · SMA20: $0.98 · SMA50: $1.01
ASTI NASDAQ
Ascent Solar Technologies, Inc. Common Stock
Semiconductors & Related Devices
$0.77
-9.55% 1D
Market Cap $12.6M
TTM Revenue $338,161
Forward P/E 14.4x
Beta / 30D Vol 4.37β · 123% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 59.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -24.6%), weak momentum, RSI 20
RSI-14: 20.4 · SMA20: $1.40 · SMA50: $2.00

6-Pillar Scorecard Institutional Category Breakdown (ABVC 2 – 3 ASTI)

Columns: Metric · ABVC · ASTI
1. Valuation Multiples ASTI
Forward P/E N/M 14.4x
Trailing P/E N/M 14.4x
PEG Ratio N/M 0.96x
EV / Revenue 29.9x N/M
2. Growth & Scale ABVC
Revenue Growth (YoY) +104.5% +514.3%
Earnings Growth (YoY) +0.0% -90.2%
TTM Revenue (USD) $797,916 $338,161
Market Cap $23.9M $12.6M
3. Profitability & Quality ABVC
Gross Margin 100.0% N/A
Operating Margin 0.0% -2759.6%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -52.7% -111.3%
4. Balance Sheet & Cash Flow ASTI
Cash Generation (TTM) -$5.8M EBITDA -$7.4M
Cash Flow Margin N/A N/A
Net Cash / Leverage $0.50 Book/Sh · -52.7% ROE $13M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ASTI
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 104.4% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Solar Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABVC (6) vs ASTI (3)
Institutional Metric ABVC ASTI Criterion Row Edge
Market Capitalization
Scale
$23.9M $12.6M Larger Scale ABVC
Trailing P/E Ratio
Valuation
N/M 14.4x Lower Multiple ASTI
Forward P/E Ratio
Valuation
N/M 14.4x Lower Multiple ASTI
Revenue Growth (YoY)
Growth
+104.5% +514.3% Higher Growth ASTI
Operating Margin (TTM)
Profitability
0.0% -2759.6% Higher Margin ABVC
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-52.7% -111.3% Higher ROE ABVC
52-Week Range Position
Momentum
7% ($1–$3) 0% ($1–$10) Stronger Trend ABVC
Beta / 30D Volatility
Risk Regime
1.24β · 44% Vol 4.37β · 123% Vol Lower Realized Risk ABVC
Unified Institutional Score
Composite Signal
47.4 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite ABVC
Trailing 12M Revenue (USD)
Operating Scale
$797,916 $338,161 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 29.9x EV/Rev 0.96x PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$5.8M EBITDA ($0.50 Book/Sh · -52.7% ROE) -$7.4M ($13M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABVC +39.1 pp
ABVC: -17.28% · ASTI: -56.38%
3M Horizon ABVC +77.65 pp
ABVC: +3.13% · ASTI: -74.52%
6M Horizon ABVC +61.59 pp
ABVC: -24.01% · ASTI: -85.6%
1Y Horizon ASTI +15.8 pp
ABVC: -68.15% · ASTI: -52.35%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs ASTI. Trailing 12-month operating profitability (ABVC 0.0% vs ASTI -2759.6%) and valuation multiples (ABVC N/M vs ASTI 14.4x Forward P/E) are benchmarked directly in Pillar 4 below.

ABVC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$797,916
Gross Margin100.0%
Op. Margin0.0%
ROE / Fwd P/E-52.7% · N/M
ASTI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$338,161
Gross MarginN/A
Op. Margin-2759.6%
ROE / Fwd P/E-111.3% · 14.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABVC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABVC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ASTI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 104.4%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ASTI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABVC Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $23.9M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ASTI Moat Profile Cyclical / Execution-Driven Positioning
Solar Operator
Competes within the Solar value chain with $12.6M market capitalization and -2759.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ABVC vs ASTI Key Questions & Quantitative Answers

As of Nov 20, 2026, ABVC BioPharma, Inc. (ABVC) captures the overall head-to-head institutional edge over Ascent Solar Technologies, Inc. (ASTI) on higher Unified Composite conviction (47.4/100 HOLD vs. 44.5/100 HOLD) after splitting the core matrix 6–3 (led by Growth & Scale, Profitability & Quality), while ASTI wins 3–2 across the 6-pillar growth and valuation breakdown. ABVC trades at $0.87 (N/M Forward P/E, 0.0% operating margin) versus ASTI at $0.77 (14.4x Forward P/E, -2759.6% operating margin). Growth vs. Quality Trade-Off: ABVC earns the overall head-to-head edge with a stronger Unified Composite Score (47.4/100 HOLD vs. ASTI 44.5/100 HOLD) and 1.24β · 44% Vol risk profile, whereas ASTI leads top-line expansion (+514.3% YoY revenue growth, 0.96x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: ABVC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 35.2); meanwhile ASTI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ABVC leads the Growth & Scale pillar: ABVC posts +104.5% YoY revenue growth and +0.0% YoY earnings growth on $797,916 TTM revenue (100.0% gross margin, 0.0% operating margin), compared with ASTI at +514.3% YoY revenue growth and -90.2% YoY earnings growth on $338,161 TTM revenue (N/A gross margin, -2759.6% operating margin). On trailing 12-month operating scale, ABVC generates $797,916 in USD-normalized revenue versus $338,161 for ASTI. In operating R&D and SG&A reinvestment, ABVC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ASTI.

ASTI screens cheaper on headline valuation multiples. ABVC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 29.9x EV/Revenue (unreported EBITDA margin), whereas ASTI trades at 14.4x Forward P/E, 14.4x Trailing P/E, 0.96x PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVC (-52.7% ROE) versus ASTI (-111.3% ROE) capital efficiency.

In options market volatility and institutional positioning, ABVC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.24β · 44% Vol realized risk). By comparison, ASTI carries 104.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.37β · 123% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.